Gene therapy: development of immunostimulatory treatments for cancer

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.

British journal of cancer·2009

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.

Gene therapy·2007

Combining gene and immunotherapy for prostate cancer.

Prostate cancer and prostatic diseases·2007

Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycle.

Gene therapy·2007

Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.

Gene therapy·2005

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.

Gene therapy·2004

Dual-energy Computed Tomography (DECT) predicts the efficacy of contrast medium extravasation and secondary cerebral hemorrhage after stent thrombectomy in acute ischemic cerebral infarction.

Biotechnology & genetic engineering reviews·2024

Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer.

Biotechnology & genetic engineering reviews·2024

Application of blood purification technology in severe fever with thrombocytopenia syndrome.

Biotechnology & genetic engineering reviews·2023

LINC00460 contributes to colorectal cancer cell invasion.

Biotechnology & genetic engineering reviews·2023

CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma.

Biotechnology & genetic engineering reviews·2023

Effect of interventional embolization based on absolute ethanol for peripheral arteriovenous malformations.

Biotechnology & genetic engineering reviews·2023

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Frontiers in medicine·2026

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

BMC gastroenterology·2026

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

MedScience·2026

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

Journal of neurointerventional surgery·2026

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Colloids and surfaces. B, Biointerfaces·2026

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Cancer treatment and research communications·2026

Related Experiment Videos

Gene therapy: development of immunostimulatory treatments for cancer

Related Concept Videos

E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.

Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.

Combining gene and immunotherapy for prostate cancer.

Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycle.

Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.

Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.

Dual-energy Computed Tomography (DECT) predicts the efficacy of contrast medium extravasation and secondary cerebral hemorrhage after stent thrombectomy in acute ischemic cerebral infarction.

Maximal clique centrality and bottleneck genes as novel biomarkers in ovarian cancer.

Application of blood purification technology in severe fever with thrombocytopenia syndrome.

LINC00460 contributes to colorectal cancer cell invasion.

CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma.

Effect of interventional embolization based on absolute ethanol for peripheral arteriovenous malformations.

Generational safety profiles of BTK inhibitors: adverse reaction signals and real-world evidence from the FAERS database.

Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients.

Neoantigen cancer vaccines for gastrointestinal tumors: opportunities and challenges.

Anxiety and mood disorders are associated with greater healthcare and procedural utilization in idiopathic intracranial hypertension.

sFgl2‑enriched MSC-EVs attenuate colitis by enhancing immunoregulatory capacity.

Patterns and outcomes of emergency department visits by patients receiving immune checkpoint inhibitors: a single-center, retrospective study.

Related Experiment Videos

Gene therapy: development of immunostimulatory treatments for cancer

Related Concept Videos

Related Articles